computer-generated randomisation scheme (AstraZeneca ltd)
90
Structured Review
AstraZeneca ltd
computer-generated randomisation scheme
Computer Generated Randomisation Scheme, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computer-generated+randomisation+scheme/computer+generated+randomization+scheme/pm24499168-61-28-32
Average 90 stars, based on 1 article reviews
Computer Generated Randomisation Scheme, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computer-generated+randomisation+scheme/computer+generated+randomization+scheme/pm24499168-61-28-32
Average 90 stars, based on 1 article reviews
computer-generated randomisation scheme - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Health-related quality of life (EQ-5D) among type 2 diabetes mellitus patients treated with dapagliflozin over 2 years. Article Snippet: Aims: This study evaluated health status and health-related quality of life (HRQOL) among patients with type 2 diabetes mellitus (T2DM) treated with dapagliflozin, a highly selective sodium-glucose co-transporter 2 (SGLT2) inhibitor that lowers blood glucose by increasing glucose excretion, in a double-blind, randomised clinical trial.. Methods: Subjects with T2DM who had inadequate glycaemic control on metformin alone were enrolled in a 24-week, double-blind, randomised, placebocontrolled study with a 78-week extension period to evaluate the effect of dapagliflozin in combination with metformin.. Subjects treated with dapagliflozin 10 mg + metformin (n = 89) were compared with subjects treated with placebo + metformin (n = 91) at baseline and at weeks 24, 50 and 102. |